Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ACAD
Tag: NASDAQ:ACAD
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy rating reiterated by JPMorgan...
ME Staff
-
September 10, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Overweight rating reiterated by Cantor...
ME Staff
-
August 27, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy rating reiterated by Needham...
ME Staff
-
August 5, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy ➝ Buy rating reiterated...
ME Staff
-
July 23, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) price target lowered to $34.00 by Needham...
ME Staff
-
July 23, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Buy rating reiterated by Needham...
ME Staff
-
July 1, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Files An 8-K Other Events
ME Staff 8-k
-
March 6, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Files An 8-K Other Events
ME Staff 8-k
-
March 6, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Hold ➝ In-Line rating reiterated...
ME Staff
-
February 27, 2019
0
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has coverage initiated with a Hold rating...
ME Staff
-
December 10, 2018
0
1
2
3
...
5
Page 2 of 5
